Clinical trial, Phase III
Showing 1 - 25 of >10,000
Essential Hypertension Trial (NW Roselle, Captopril 25Mg Tab)
Not yet recruiting
- Essential Hypertension
- NW Roselle
- Captopril 25Mg Tab
- (no location specified)
Nov 15, 2023
Anastomotic Complication, Anastomotic Leak Small Intestine, Anastomotic Leak Large Intestine Trial in Sevilla (Damage Control
Recruiting
- Anastomotic Complication
- +2 more
- Damage Control Surgery
-
Sevilla, SpainHospital Universitario Virgen del Rocío, Sevilla
Jun 11, 2022
HR+/HER2-breast Cancer Trial (Standard endocrine therapy plus Apatinib)
Not yet recruiting
- HR+/HER2-breast Cancer
- Standard endocrine therapy plus Apatinib
- (no location specified)
Jun 2, 2023
Hepatic Ascites Trial in Guangdong (Recombinant Human Serum Albumin, Human serum albumin)
Not yet recruiting
- Hepatic Ascites
- Recombinant Human Serum Albumin
- Human serum albumin
-
Guangdong, Shenzhen, ChinaShenzhen Protgen Ltd
May 5, 2023
NSCLC Trial (Idylla EGFR_IUO/3.20 Mutation Test)
Not yet recruiting
- NSCLC
- Idylla EGFR_IUO/3.20 Mutation Test
- (no location specified)
Jul 24, 2023
Atopic Dermatitis Trial in Beijing (Jaktinib Hydrochloride Tablet)
Recruiting
- Atopic Dermatitis
- Jaktinib Hydrochloride Tablet
-
Beijing, Beijing, China11 Xizhimen South Street
Jan 6, 2023
COVID-19 SARS-CoV-2 Infection Trial (CoronaVac, SCTV01E)
Not yet recruiting
- COVID-19 SARS-CoV-2 Infection
- CoronaVac
- SCTV01E
- (no location specified)
Jan 4, 2023
Hamstring Injury Trial in Pittsburgh (Losartan, )
Recruiting
- Hamstring Injury
- Losartan
- placebo
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh
Dec 14, 2022
Norovirus Infections, Norwalk Gastroenteritis Trial (Human Norovirus Bivalent (G?.1/G?.4)Vaccine,Recombinant (Hansenula
Not yet recruiting
- Norovirus Infections
- Norwalk Gastroenteritis
- Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine,Recombinant (Hansenula polymorpha)
- placebo
- (no location specified)
Jun 14, 2023
HER2-positive Breast Cancer Trial in Nanjing (HS022, Trastuzumab, Vinorelbine Bitartrate)
Completed
- HER2-positive Breast Cancer
- HS022
- +2 more
-
Nanjing, Jiangsu, ChinaJiangsu Province People's Hospital (First Affiliated Hospital of
Oct 25, 2023
COVID-19, Symptoms and Signs, COVID-19 Pandemic Trial in Cortés (Chlorpheniramine Maleate 0.4% Nasal Spray, Placebo)
Completed
- COVID-19
- +4 more
- Chlorpheniramine Maleate 0.4% Nasal Spray
- Placebo
-
Cortés, San Pedro Sula, HondurasHospital CEMESA
Jun 1, 2023
MPS IIIA, Sanfilippo Syndrome, Sanfilippo A Trial in Australia, Spain, United States (ABO-102)
Active, not recruiting
- MPS IIIA
- +3 more
- ABO-102
-
Columbus, Ohio
- +4 more
Nov 8, 2022
Seasonal Influenza Trial in China (Quadrivalent influenza vaccine(0.25ml), Quadrivalent influenza vaccine(0.5ml), Trivalent
Not yet recruiting
- Seasonal Influenza
- Quadrivalent influenza vaccine(0.25ml)
- +3 more
-
Lu'an, Anhui, China
- +4 more
Sep 15, 2023
Epidermolysis Bullosa Trial in Minneapolis (allo-APZ2-OTS, Placebo)
Not yet recruiting
- Epidermolysis Bullosa
- allo-APZ2-OTS
- Placebo
-
Minneapolis, MinnesotaMasonic Cancer Center and Medical Center Minneapolis
Apr 20, 2023
Varicella Trial in Xuzhou (Investigational live attenuated varicella vaccine, Placebo of live attenuated varicella vaccine)
Recruiting
- Varicella
- Investigational live attenuated varicella vaccine
- Placebo of live attenuated varicella vaccine
-
Xuzhou, Jiangsu, ChinaPei County Center for Disease Control and Prevention
Jan 18, 2023
Amyotrophic Lateral Sclerosis Trial (Acetyl-l-carnitine, Placebo)
Not yet recruiting
- Amyotrophic Lateral Sclerosis
- Acetyl-l-carnitine
- Placebo
- (no location specified)
Nov 9, 2023
Glabellar Lines Trial (Botulinum Toxin Type A Injection [HG102], Botulinum Toxin Type A Injection [Botox])
Not yet recruiting
- Glabellar Lines
- Botulinum Toxin Type A Injection [HG102]
- Botulinum Toxin Type A Injection [Botox]
- (no location specified)
Apr 5, 2023
Moderate to Severe Active Rheumatoid Arthritis Trial in Beijing (HS628+MTX, Actemra +MTX)
Completed
- Moderate to Severe Active Rheumatoid Arthritis
- HS628+MTX
- Actemra +MTX
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Sep 14, 2023
Melanoma Stage III Trial in Shanghai (Toripalimab combined with Temozolomide)
Not yet recruiting
- Melanoma Stage III
- Toripalimab combined with Temozolomide
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Apr 23, 2023
Glabellar Frown Lines Trial (PROTOXIN)
Not yet recruiting
- Glabellar Frown Lines
- PROTOXIN
- (no location specified)
Nov 8, 2023
Stress Ulcer Bleeding Trial in Shanghai, Urumchi (Esomeprazole 40mg, Ilaprazole Sodium, Placebo 1)
Completed
- Stress Ulcer Bleeding
- Esomeprazole 40mg
- +3 more
-
Shanghai, Shanghai, China
- +1 more
Apr 22, 2023
COVID-19 Trial in Xi'an (Meplazumab for injection, Normal saline)
Recruiting
- COVID-19
- Meplazumab for injection
- Normal saline
-
Xi'an, ChinaFirst Affiliated Hospital of the Air Force Medical University
Apr 13, 2023
Breast Cancer, Triple Negative Breast Cancer Trial (Antivascular therapy, Chemotherapy)
Not yet recruiting
- Breast Cancer
- Triple Negative Breast Cancer
- Antivascular therapy
- Chemotherapy
- (no location specified)
Jun 11, 2023